Obesity May Suppress Natural Breast Cancer Defense Mechanism

Researchers have identified a potential biological mechanism that may explain why obesity is linked to more aggressive breast cancer. A study published in the journal Science suggests that lean breast fat tissue naturally produces a protective lipid molecule that helps restrain tumor growth, a defense that appears to be diminished in obese individuals.

The research team, led by investigators at the University of Utah and the Huntsman Cancer Institute, found that lean adipocytes release a specific fat molecule called 9S-HODE. This molecule triggers a process known as ferroptosis, a form of cell death driven by iron-dependent lipid damage, which effectively slows the growth of breast cancer cells. In laboratory and mouse models, the researchers observed that obese fat cells produced significantly lower levels of this protective signal, leaving tumors less constrained.

To determine how lean fat cells inhibit cancer, the researchers isolated substances released by adipocytes. They discovered that fluid from lean fat cells slowed the growth of seven different mouse and human breast cancer cell lines, whereas fluid from obese adipocytes did not. Further investigation revealed that the active agent was 9S-HODE, a lipid produced with the help of the enzyme 5-LOX. When the team blocked this enzyme, the protective effect was significantly weakened.

The study also highlighted how cancer cells and normal cells respond differently to this signal. Normal breast cells protect themselves from ferroptosis by storing excess fats in small droplets, preventing the lipid damage that 9S-HODE would otherwise trigger. Conversely, when cancer cells were experimentally given the ability to store fats in similar droplets, they became resistant to the protective signal, suggesting that the ability to manage lipid storage is a key factor in tumor survival.

In experiments with obese mice, the researchers attempted to restore this natural defense by injecting 9S-HODE directly into established tumors. This intervention successfully slowed tumor growth across four different breast cancer models. While these results are promising, the researchers emphasized that the treatment is not yet a proven therapy. Questions remain regarding the safety of systemic delivery, appropriate dosing, and whether such an approach would improve clinical outcomes in human patients.

Human tissue samples provided additional support for the findings, showing that levels of 9-HODE in breast fat decrease as body mass index increases. However, the researchers noted that this observation demonstrates an association rather than direct causation. The study represents an early step in understanding the complex relationship between obesity and cancer, with further research required to determine if this natural lipid pathway can be harnessed for therapeutic use.